Bone marrow-derived humoral factors suppress oxidative phosphorylation, upregulate TSG-6, and improve therapeutic effects on liver injury of mesenchymal stem cells

DOI Web Site 参考文献41件 オープンアクセス
  • Miyaji Takashi
    Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine
  • Takami Taro
    Department of Liver Regenerative Medicine, Yamaguchi University Graduate School of Medicine Center for Regenerative and Cell Therapy, Yamaguchi University Organization for Research Initiatives
  • Fujisawa Koichi
    Department of Liver Regenerative Medicine, Yamaguchi University Graduate School of Medicine
  • Matsumoto Toshihiko
    Department of Oncology and Laboratory Medicine, Yamaguchi University Graduate School of Medicine
  • Yamamoto Naoki
    Health Administration Center, Yamaguchi University
  • Sakaida Isao
    Department of Gastroenterology & Hepatology, Yamaguchi University Graduate School of Medicine Center for Regenerative and Cell Therapy, Yamaguchi University Organization for Research Initiatives

この論文をさがす

抄録

<p>Mesenchymal stem cells, which have the potential to be used in regenerative medicine, require improvements in quality for patient use. To maintain stemness of cultured bone marrow-derived mesenchymal stem cells, we focused on the bone marrow microenvironment, generated a conditioned medium of whole bone marrow cells (BMC-CM), and assessed its effects on bone marrow-derived mesenchymal stem cells. BMC-CM suppressed morphological deterioration and proliferative decline in cultured bone marrow-derived mesenchymal stem cells, suppressed mitochondrial oxidative phosphorylation activity, a stemness indicator, and upregulated suppressors of oxidative phosphorylation such as hypoxia-inducible factor-1 alpha, Sirtuin 3, 4, and 5. Furthermore, BMC-CM upregulated TNF-stimulated gene 6 and ameliorated the therapeutic effects of cells on liver injury in carbon tetrachloride-administered rats. Since the elimination of 20–220-nm particles attenuated the effects of BMC-CM, we further analyzed exosomal microRNAs produced by whole bone marrow cells. Among the 49 microRNAs observed to be upregulated during the preparation of BMC-CM, several were identified that were associated with suppression of oxidative phosphorylation, upregulation of TNF-stimulated gene 6, and the pathogenesis of liver diseases. Thus, bone marrow-derived humoral factors including exosomal microRNAs may help to improve the therapeutic quality of bone marrow-derived mesenchymal stem cells for liver regenerative therapy.</p>

収録刊行物

参考文献 (41)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ